Harga beli
25,33
25,33
25,32
233.06 B
Informasi tentang kinerja di masa lalu bukanlah indikator kinerja di masa mendatang yang dapat diandalkan.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Buat akun dan selesaikan verifikasi singkat.
Tambahkan dana ke dompet Anda melalui kartu, transfer bank, atau kripto.
Pilih PFE, tentukan jumlahnya, lalu klik beli atau jual — selesai!
Pfizer Inc.
PFE
25,325
+0.68%
FAQ